Adherence to tyrosine kinase inhibitors among Medicare Part D beneficiaries with chronic myeloid leukemia

CONCLUSIONSThe current population‐based study found a significantly higher rate of nonadherence among heavily subsidized patients with substantially lower out‐of‐pocket costs, which suggests that future research is needed to help lower the nonadherence rate among these individuals. Cancer 2017. © 2017 American Cancer Society.

Source: Cancer - October 4, 2017 Category: Cancer & Oncology Authors: Chan Shen, Bo Zhao, Lei Liu, Ya ‐Chen Tina Shih Tags: Original Article Source Type: research